AutoMed-Int: Medical Follow-up and Self-medication Among Medical Students

Sponsor
Université de Reims Champagne-Ardenne (Other)
Overall Status
Completed
CT.gov ID
NCT05578911
Collaborator
(none)
264
1
1.1
243.5

Study Details

Study Description

Brief Summary

As health actors, medical students educate patients to have regular medical follow-up and give them justified medical prescriptions. Regarding their own health, medical students do not seem to apply these same principles.

The medical follow-up of medical students seems insufficient, which can be explained by the lack of medical follow-up by occupational medicine, a consequent work time, but also the fear of judgment by colleagues Moreover, medical student have an easy access to all types of prescriptions and therefore the ease of self-prescription and self-medication. Medical students may also overestimate their medical knowledge and may not be objective about their symptomatology.

Condition or Disease Intervention/Treatment Phase
  • Other: "medical students" group

Detailed Description

The aim of the study will be to describe medical follow-up and self-medication among medical students

Study Design

Study Type:
Observational
Actual Enrollment :
264 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Medical Follow-up and Self-medication Among Medical Students
Actual Study Start Date :
Oct 5, 2022
Actual Primary Completion Date :
Nov 7, 2022
Actual Study Completion Date :
Nov 7, 2022

Outcome Measures

Primary Outcome Measures

  1. self-medication [Day 0]

    Number of medical students with prescription for themself of a medical treatment

Secondary Outcome Measures

  1. self-prescription [Day 0]

    Number of medical students with prescription for themself of an biological analysis and/or a medical imaging

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • medical student in general practice or in specialty medicine

  • agreeing to participate in the study

Exclusion Criteria:
  • none

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ufr Medecine Urca Reims France 51100

Sponsors and Collaborators

  • Université de Reims Champagne-Ardenne

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Université de Reims Champagne-Ardenne
ClinicalTrials.gov Identifier:
NCT05578911
Other Study ID Numbers:
  • 2022_RIPH_005_AutoMed-Int
First Posted:
Oct 13, 2022
Last Update Posted:
Nov 14, 2022
Last Verified:
Oct 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Université de Reims Champagne-Ardenne

Study Results

No Results Posted as of Nov 14, 2022